Meeder Advisory Services Inc. Has $1.11 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Meeder Advisory Services Inc. raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 10.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,245 shares of the medical research company’s stock after buying an additional 794 shares during the quarter. Meeder Advisory Services Inc.’s holdings in Agilent Technologies were worth $1,108,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of A. Groupama Asset Managment raised its stake in Agilent Technologies by 19.0% during the 4th quarter. Groupama Asset Managment now owns 12,834 shares of the medical research company’s stock worth $1,725,000 after buying an additional 2,045 shares during the period. Cannon Advisors Inc. increased its holdings in shares of Agilent Technologies by 6.9% in the fourth quarter. Cannon Advisors Inc. now owns 3,026 shares of the medical research company’s stock worth $407,000 after acquiring an additional 196 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company’s stock worth $938,291,000 after purchasing an additional 53,992 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Agilent Technologies by 0.6% during the 4th quarter. Wellington Management Group LLP now owns 9,306,805 shares of the medical research company’s stock valued at $1,250,276,000 after purchasing an additional 59,781 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC grew its position in shares of Agilent Technologies by 9.8% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 37,177 shares of the medical research company’s stock valued at $4,994,000 after purchasing an additional 3,327 shares during the period.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 5,638 shares of company stock worth $731,229.

Agilent Technologies Trading Up 1.7 %

NYSE A opened at $115.96 on Thursday. Agilent Technologies, Inc. has a 12 month low of $112.75 and a 12 month high of $155.35. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The stock has a 50 day moving average of $132.16 and a 200-day moving average of $136.18. The company has a market cap of $33.06 billion, a PE ratio of 26.66, a PEG ratio of 3.20 and a beta of 1.19.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.86%. Agilent Technologies’s payout ratio is 22.76%.

Analyst Upgrades and Downgrades

A has been the topic of a number of research reports. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Bank of America cut their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Citigroup boosted their price target on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, Robert W. Baird decreased their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $150.83.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.